Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Silk Road Medical
company
About
Silk Road Medical provides research and development services of medical devices for neurovascular diseases.
- 101 - 250
Highlights
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $47M
- Industries
- Health Care,Medical,Medical Device
- Founded date
- Jan 1, 2007
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Silk Road Medical believes that by innovating around proven surgical principles and developing breakthrough technology for vascular specialists, we can improve the lives of people with arterial disease. Our history is one of deep collaboration with vascular surgeons and our future will be guided by continuous learning, observation, and improvement. Silk Road advances patient care. Silk Road Medical Inc. was founded in 2007 and is based in Sunnyvale, California.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$47M
Silk Road Medical has raised a total of
$47M
in funding over 2 rounds. Their latest funding was raised on
Jul 18, 2017 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 18, 2017 | Series C | $47M | 1 |
Norwest Venture Partners
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Silk Road Medical is funded by 1 investors.
Norwest Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Norwest Venture Partners
|
Yes | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
